title: Insulinlike growth factor-1 receptor: predictive factor in breast cancer patients treated with trastuzumab?
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Paolo
authors.initials: P
authors.lastname: Morandi
authors.forename: Bulent
authors.initials: B
authors.lastname: Ozcakar
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D006801:Humans; D011379:Prognosis; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017526:Receptor, IGF Type 1; D000068878:Trastuzumab